世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本のインフルエンザウイルスワクチン(H1N1)市場の洞察、2027年までの予測


Global and Japan Influenza Virus Vaccine (H1N1) Market Insights, Forecast to 2027

インフルエンザウイルスワクチン(H1N1)は、以前は豚インフルエンザとして知られていたa(H1N1)ウイルスを防御するために特別に設計されています。 市場分析と洞察。世界と日本のインフルエンザウイルスワク... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月26日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

インフルエンザウイルスワクチン(H1N1)は、以前は豚インフルエンザとして知られていたa(H1N1)ウイルスを防御するために特別に設計されています。

市場分析と洞察。世界と日本のインフルエンザウイルスワクチン(H1N1)市場
本レポートでは、世界と日本のインフルエンザウイルスワクチン(H1N1)市場に焦点を当てています。
2020年のインフルエンザウイルスワクチン(H1N1)の世界市場規模はXX百万米ドルで、2021年から2027年の間にXX%のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、インフルエンザウイルスワクチン(H1N1)の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予想されています。

世界のインフルエンザウイルスワクチン(H1N1)の範囲と市場規模
インフルエンザウイルスワクチン(H1N1)市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のインフルエンザウイルスワクチン(H1N1)市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当て、2016年から2027年の期間で収益と予測を示しています。
日本市場では、2016-2027年のインフルエンザウイルスワクチン(H1N1)の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
筋注用ワクチン
鼻腔内投与ワクチン

用途別セグメント
3歳から10歳まで
10歳以上18歳未満
18歳以上
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
CSL
NVS(ノバルティス)
サノフィパスツール(Sanofi Pasteur)
メディミューン
GSK
バクスター
北京克星バイオワクチン
華蘭バイオワクチン(Hualan Bio-Vaccine
長春長生生物技術有限公司(Changchun Changsheng Bio-Technology
北京天壇生物製品有限公司
江蘇ヤンセン・バイオテクノロジー
浙江天元バイオ製薬
大連亜里峰バイオ製薬
シノファーム


ページTOPに戻る


目次

1 Study Coverage
1.1 Influenza Virus Vaccine (H1N1) Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Influenza Virus Vaccine (H1N1) Market Size, Estimates and Forecasts
2.1.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027
2.1.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027
2.2 Global Influenza Virus Vaccine (H1N1), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza Virus Vaccine (H1N1) Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027)

3 Global Influenza Virus Vaccine (H1N1) Competitor Landscape by Players
3.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales
3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue
3.2.1 Key Influenza Virus Vaccine (H1N1) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza Virus Vaccine (H1N1) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2020
3.2.6 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Virus Vaccine (H1N1) Price by Manufacturers
3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Product Types
3.4.1 Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Virus Vaccine (H1N1) Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)
4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021)
4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021)
4.1.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
4.2.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)
5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021)
5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021)
5.1.3 Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
5.2 Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza Virus Vaccine (H1N1) Sales YoY Growth 2016-2027
6.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027
6.2 Japan Influenza Virus Vaccine (H1N1) Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021)
6.2.2 Japan Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021)
6.3 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)
6.4 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027)
6.5 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
6.6 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

7 North America
7.1 North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
7.2 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
7.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
7.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
9.2 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
9.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
9.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
10.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
10.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Description and Business Overview
12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.1.5 CSL Recent Development
12.2 NVS(Novartis)
12.2.1 NVS(Novartis) Corporation Information
12.2.2 NVS(Novartis) Description and Business Overview
12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered
12.2.5 NVS(Novartis) Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Medimmune
12.4.1 Medimmune Corporation Information
12.4.2 Medimmune Description and Business Overview
12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
12.4.5 Medimmune Recent Development
12.5 GSK
12.5.1 GSK Corporation Information
12.5.2 GSK Description and Business Overview
12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
12.5.5 GSK Recent Development
12.6 Baxter
12.6.1 Baxter Corporation Information
12.6.2 Baxter Description and Business Overview
12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
12.6.5 Baxter Recent Development
12.7 Beijing Kexing Bio-Vaccine
12.7.1 Beijing Kexing Bio-Vaccine Corporation Information
12.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview
12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.7.5 Beijing Kexing Bio-Vaccine Recent Development
12.8 Hualan Bio-Vaccine
12.8.1 Hualan Bio-Vaccine Corporation Information
12.8.2 Hualan Bio-Vaccine Description and Business Overview
12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.8.5 Hualan Bio-Vaccine Recent Development
12.9 Changchun Changsheng Bio-Technology
12.9.1 Changchun Changsheng Bio-Technology Corporation Information
12.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
12.9.5 Changchun Changsheng Bio-Technology Recent Development
12.10 Beijing Tiantan Bio-Products
12.10.1 Beijing Tiantan Bio-Products Corporation Information
12.10.2 Beijing Tiantan Bio-Products Description and Business Overview
12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered
12.10.5 Beijing Tiantan Bio-Products Recent Development
12.11 CSL
12.11.1 CSL Corporation Information
12.11.2 CSL Description and Business Overview
12.11.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.11.5 CSL Recent Development
12.12 Zhejiang Tianyuan Bio-Pharmaceutical
12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered
12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
12.13 Dalian Yalifeng Bio-Pharmaceutical
12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
12.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered
12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
12.14 Sinopharm
12.14.1 Sinopharm Corporation Information
12.14.2 Sinopharm Description and Business Overview
12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sinopharm Products Offered
12.14.5 Sinopharm Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza Virus Vaccine (H1N1) Industry Trends
13.2 Influenza Virus Vaccine (H1N1) Market Drivers
13.3 Influenza Virus Vaccine (H1N1) Market Challenges
13.4 Influenza Virus Vaccine (H1N1) Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Virus Vaccine (H1N1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.

Market Analysis and Insights: Global and Japan Influenza Virus Vaccine (H1N1) Market
This report focuses on global and Japan Influenza Virus Vaccine (H1N1) market.
In 2020, the global Influenza Virus Vaccine (H1N1) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Influenza Virus Vaccine (H1N1) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Influenza Virus Vaccine (H1N1) Scope and Market Size
Influenza Virus Vaccine (H1N1) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Virus Vaccine (H1N1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Influenza Virus Vaccine (H1N1) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Intramuscular Vaccine
Nasal Spray Vaccine

Segment by Application
3 To 10 Years Old
10 To 18 Years Old
Above 18 Years Old
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Influenza Virus Vaccine (H1N1) Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Influenza Virus Vaccine (H1N1) Market Size, Estimates and Forecasts
2.1.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027
2.1.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027
2.2 Global Influenza Virus Vaccine (H1N1), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza Virus Vaccine (H1N1) Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027)

3 Global Influenza Virus Vaccine (H1N1) Competitor Landscape by Players
3.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales
3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue
3.2.1 Key Influenza Virus Vaccine (H1N1) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza Virus Vaccine (H1N1) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2020
3.2.6 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Virus Vaccine (H1N1) Price by Manufacturers
3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Product Types
3.4.1 Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Virus Vaccine (H1N1) Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)
4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021)
4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021)
4.1.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
4.2.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)
5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021)
5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021)
5.1.3 Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
5.2 Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza Virus Vaccine (H1N1) Sales YoY Growth 2016-2027
6.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027
6.2 Japan Influenza Virus Vaccine (H1N1) Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021)
6.2.2 Japan Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021)
6.3 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)
6.4 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027)
6.5 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
6.6 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

7 North America
7.1 North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
7.2 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
7.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
7.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
9.2 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
9.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
9.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
10.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
10.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Description and Business Overview
12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.1.5 CSL Recent Development
12.2 NVS(Novartis)
12.2.1 NVS(Novartis) Corporation Information
12.2.2 NVS(Novartis) Description and Business Overview
12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered
12.2.5 NVS(Novartis) Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Medimmune
12.4.1 Medimmune Corporation Information
12.4.2 Medimmune Description and Business Overview
12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
12.4.5 Medimmune Recent Development
12.5 GSK
12.5.1 GSK Corporation Information
12.5.2 GSK Description and Business Overview
12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
12.5.5 GSK Recent Development
12.6 Baxter
12.6.1 Baxter Corporation Information
12.6.2 Baxter Description and Business Overview
12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
12.6.5 Baxter Recent Development
12.7 Beijing Kexing Bio-Vaccine
12.7.1 Beijing Kexing Bio-Vaccine Corporation Information
12.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview
12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.7.5 Beijing Kexing Bio-Vaccine Recent Development
12.8 Hualan Bio-Vaccine
12.8.1 Hualan Bio-Vaccine Corporation Information
12.8.2 Hualan Bio-Vaccine Description and Business Overview
12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.8.5 Hualan Bio-Vaccine Recent Development
12.9 Changchun Changsheng Bio-Technology
12.9.1 Changchun Changsheng Bio-Technology Corporation Information
12.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
12.9.5 Changchun Changsheng Bio-Technology Recent Development
12.10 Beijing Tiantan Bio-Products
12.10.1 Beijing Tiantan Bio-Products Corporation Information
12.10.2 Beijing Tiantan Bio-Products Description and Business Overview
12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered
12.10.5 Beijing Tiantan Bio-Products Recent Development
12.11 CSL
12.11.1 CSL Corporation Information
12.11.2 CSL Description and Business Overview
12.11.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.11.5 CSL Recent Development
12.12 Zhejiang Tianyuan Bio-Pharmaceutical
12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered
12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
12.13 Dalian Yalifeng Bio-Pharmaceutical
12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
12.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered
12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
12.14 Sinopharm
12.14.1 Sinopharm Corporation Information
12.14.2 Sinopharm Description and Business Overview
12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sinopharm Products Offered
12.14.5 Sinopharm Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza Virus Vaccine (H1N1) Industry Trends
13.2 Influenza Virus Vaccine (H1N1) Market Drivers
13.3 Influenza Virus Vaccine (H1N1) Market Challenges
13.4 Influenza Virus Vaccine (H1N1) Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Virus Vaccine (H1N1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(抗生物薬)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る